Novartis India Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Novartis India Limited with three other
companies in this sector in India:
Eris Lifesciences Ltd
sales of 7.25 billion Indian Rupees [US$112.80 million]
of which 100%
Ind-Swift Laboratories Limited
(7.18 billion Indian Rupees [US$111.74 million]
Morepen Laboratories Limited
(5.84 billion Indian Rupees [US$90.86 million]
Novartis India Limited reported sales of 6.56 billion Indian Rupees (US$102.11 million)
March of 2017.
decrease of 18.8%
versus 2016, when the company's sales were 8.08 billion Indian Rupees.